BML264 ((E)-N-(p-amylcinnamoyl) anthranilic acid) is an agonist for TREK-1 . BML264 can be used to study diseases associated with TASK1 dysfunction.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Potassium Channel
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.